Sun Pharma Shares Jump 7% on $11.75 Billion Organon Acquisition
Sun Pharma shares rose 7% after announcing an $11.75 billion deal to acquire U.S.-based Organon, expanding its global footprint.
#Organon
Explore MarketSpeaker's latest reporting, research, and expert analysis tagged with "organon", collected in one continuously updated archive.
Related Posts